Cargando…

Development of a novel lipid metabolism-based risk score model in hepatocellular carcinoma patients

BACKGROUND: Liver cancer is one of the most common malignancies worldwide. HCC (hepatocellular carcinoma) is the predominant pathological type of liver cancer, accounting for approximately 75–85 % of all liver cancers. Lipid metabolic reprogramming has emerged as an important feature of HCC. However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Wenjie, Zhang, Chen, Yu, Qihong, Zheng, Xichuan, Yin, Chuanzheng, Yan, Xueke, Liu, Gang, Song, Zifang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881464/ https://www.ncbi.nlm.nih.gov/pubmed/33579192 http://dx.doi.org/10.1186/s12876-021-01638-3

Ejemplares similares

Sox9 mediates autophagy-dependent vascular smooth muscle cell phenotypic modulation and transplant arteriosclerosis
por: Yu, Qihong, et al.
Publicado: (2022)

High BLM Expression Predicts Poor Clinical Outcome and Contributes to Malignant Progression in Human Cholangiocarcinoma
por: Du, Xiaolong, et al.
Publicado: (2021)

Nuclear respiratory factor 1 drives hepatocellular carcinoma progression by activating LPCAT1-ERK1/2-CREB axis
por: Liu, Ran, et al.
Publicado: (2023)

Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma
por: Sangineto, Moris, et al.
Publicado: (2020)

Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
por: Li, Min, et al.
Publicado: (2016)

Theranostic Nanodots with Aggregation-Induced Emission Characteristic for Targeted and Image-Guided Photodynamic Therapy of Hepatocellular Carcinoma
por: Gao, Yang, et al.
Publicado: (2019)

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
por: Nakagawa, Hayato, et al.
Publicado: (2018)

Development of TACE Refractoriness Scores in Hepatocellular Carcinoma
por: Chen, Li, et al.
Publicado: (2021)

Metabolic Alteration in Hepatocellular Carcinoma: Mechanism of Lipid Accumulation in Well-Differentiated Hepatocellular Carcinoma
por: Suzuki, Hideo, et al.
Publicado: (2021)

Novel Paired Cell Lines for the Study of Lipid Metabolism and Cancer Stemness of Hepatocellular Carcinoma
por: Cheng, Yun-Hsin, et al.
Publicado: (2022)

PI3Kγ promotes vascular smooth muscle cell phenotypic modulation and transplant arteriosclerosis via a SOX9-dependent mechanism
por: Yu, Qihong, et al.
Publicado: (2018)

CHRIST: CD44-Incorporated Hepatocellular Carcinoma Risk Index Scoring Tool—A Novel Prognostic Scoring System for Hepatocellular Carcinoma Development and Aggressiveness
por: Khalifa, Ahmed Ali, et al.
Publicado: (2022)

High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma
por: Xu, Jianjun, et al.
Publicado: (2022)

Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Liver Lipidomics
por: Li, Zhao, et al.
Publicado: (2017)

Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
por: Feng, Xiao-Chen, et al.
Publicado: (2023)

Interfering with lipid metabolism through targeting CES1 sensitizes hepatocellular carcinoma for chemotherapy
por: Li, Gang, et al.
Publicado: (2023)

Dietary polyphenols in lipid metabolism: A role of gut microbiome
por: Ma, Jie, et al.
Publicado: (2020)

Age-specific sex difference in the incidence of hepatocellular carcinoma in the United States
por: Liu, Pian, et al.
Publicado: (2017)

Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma
por: Ying, Leqian, et al.
Publicado: (2021)

Identification of Downregulated Exosome-Associated Gene ENPP1 as a Novel Lipid Metabolism and Immune-Associated Biomarker for Hepatocellular Carcinoma
por: Li, Zhilan., et al.
Publicado: (2022)

Development of a prognostic scoring system for resectable hepatocellular carcinoma
por: Sposito, Carlo, et al.
Publicado: (2016)

Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma
por: Ni, Wenkai, et al.
Publicado: (2021)

Machine learning-based transcriptome analysis of lipid metabolism biomarkers for the survival prediction in hepatocellular carcinoma
por: Xiong, Ronghong, et al.
Publicado: (2022)

Prognostic Score-based Clinical Factors and Metabolism-related Biomarkers for Predicting the Progression of Hepatocellular Carcinoma
por: Yan, Jia, et al.
Publicado: (2020)

A Novel Pathological Scoring System for Hepatic Cirrhosis with Hepatocellular Carcinoma
por: Dong, Wei, et al.
Publicado: (2020)

Dysregulated signaling hubs of liver lipid metabolism reveal hepatocellular carcinoma pathogenesis
por: Lee, Sunjae, et al.
Publicado: (2016)

Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinoma
por: Ju, Hye-Lim, et al.
Publicado: (2016)

Comprehensive Analysis of the Expression and Prognosis for Lipid Metabolism-Related Genes in Hepatocellular Carcinoma
por: Fan, Wen-Jie, et al.
Publicado: (2022)

Development and Validation of a Prognostic Score for Hepatocellular Carcinoma Patients in Immune Checkpoint Inhibitors Therapies: The Hepatocellular Carcinoma Modified Gustave Roussy Immune Score
por: Li, Yongjiang, et al.
Publicado: (2022)

Development and validation of risk score for predicting spontaneous rupture of hepatocellular carcinoma
por: Ye, Feng, et al.
Publicado: (2020)

A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma
por: Yang, Ti, et al.
Publicado: (2023)

Immunotherapy of Tumor RNA-Loaded Lipid Nanoparticles Against Hepatocellular Carcinoma
por: Zhang, Yake, et al.
Publicado: (2021)

Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma
por: Zheng, Yujia, et al.
Publicado: (2018)

Covered versus Uncovered Self-Expandable Metal Stents for Managing Malignant Distal Biliary Obstruction: A Meta-Analysis
por: Li, Jinjin, et al.
Publicado: (2016)

Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors
por: Sun, Lei, et al.
Publicado: (2023)

Construction of a lipid metabolism‐related and immune‐associated prognostic signature for hepatocellular carcinoma
por: Hu, Bo, et al.
Publicado: (2020)

Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review
por: Hu, Bo, et al.
Publicado: (2020)

Effects of LRP1B Regulated by HSF1 on Lipid Metabolism in Hepatocellular Carcinoma
por: Li, Miaomiao, et al.
Publicado: (2020)

Integrative analysis of the characteristic of lipid metabolism-related genes for the prognostic prediction of hepatocellular carcinoma
por: Zhu, Peng, et al.
Publicado: (2022)

A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma
por: Xu, Kequan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rc4qepf030u46aidc4j5gvbf03